Clinical trial Recruiting at 2 sites Observational Ages 18 and up

FeetSee thermal images for people with diabetes who have healed plantar ulcers

Official title: Foot Temperature and Diabetic Foot Ulcer Risk: Using the FeetSee Device to Generate a Unique Foot Temperature Dataset.

Run by Diabetis JSC · NCT07300163 · Data updated 2026-11-12

This study tests if using a FeetSee thermal camera with a smartphone can help people with diabetes who had a healed plantar ulcer catch early signs of trouble at the bottom of the feet.

More Diabetic Foot Ulcer trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorDiabetis JSC
Industry-sponsored
Locations4 sites (Vilnius and 3 other locations)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedMay 30, 2027
Study endsMay 30, 2027
Registry record updatedJune 22, 2026
Trial IDNCT07300163 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with type 1 or type 2 diabetes, a history of plantar DFU healed for at least 6 weeks, documented peripheral neuropathy, and at least one palpable foot pulse.

Probably not a fit

Patients without neuropathy, with active foot ulcers, or with severe vascular disease may not benefit from this monitoring approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational study enrolling adults with type 1 or type 2 diabetes and a recently healed plantar diabetic foot ulcer, who also have neuropathy. Participants use a FeetSee thermal camera attached to their own device to take daily plantar foot images at home, with data securely uploaded for analysis. The study aims to identify temperature patterns that may precede ulceration and to evaluate the feasibility and adherence of home-based thermal imaging in this population. Recruitment occurs at hospital sites in the UK and Lithuania, with follow-up through device support and periodic check-ins. Key exclusions include active ulcers, Charcot disease, severe vascular disease, or other conditions that would hinder safe device use.

Why it matters

Potential benefit: If successful, this approach could enable earlier detection of foot problems and prompt preventative actions to reduce ulcers and related complications.

How similar studies have gone: Previous research suggests thermal imaging can help detect inflammatory hotspots, but large-scale validation for ulcer prevention remains limited and this protocol is among early prospective observational efforts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Males/females aged over 18 years.
* Type 1 or type 2 diabetes.
* History of plantar diabetic foot ulcer(s).
* Foot ulcer healed for at least 6 weeks before entry into study, as determined by a specialist healthcare provider.
* Presence of diabetic peripheral neuropathy defined by either of the following:

  * Inability to detect the monofilament (10g) applied at two foot sites, including the apex of the Hallux (ADA guidelines 2008 Diabetes Care 31(1)).
  * A Vibration Perception Threshold (VPT) \>20V, and/or by inability to detect application of the monofilament at the apex of the Hallux.
* Presence of at least one palpable foot pulse.

Exclusion Criteria:

* Active foot ulceration.
* Active Charcot neuro-osteoarthropathy.
* Severe vascular disease (complete absence of any foot pulses).
* Lower limb/foot amputation greater than metatarsophalangeal disarticulation.
* Active malignancy, immunosuppressive disease.
* Physical or mental condition(s) that limit the ability to follow instructions for the study, based on clinical judgment by the physician, such as inability to use the device without assistance.
* Current participation in another clinical investigation of a medical device that is contraindicated for either study procedure/outcome.

Where it's running

  • Vilnius University Hospital Santaros Klinikos
    Vilnius, Lithuania
    Recruiting
  • Manchester University NHS Foundation Trust (MFT)
    Manchester, United Kingdom
    Recruiting
  • Blackpool Teaching Hospitals NHS Trust
    Blackpool, United Kingdom
    Not yet recruiting
  • Lancashire Teaching Hospitals NHS Foundation Trust
    Lancaster, United Kingdom
    Not yet recruiting

Study contacts

  • Principal investigator: Neil Reeves, Prof, Phd — Manchester University NHS Foundation Trust (MFT)
  • Study coordinator: Helena Grinberg Rashi, Phd
  • Email: helena@diabetis.lt
  • Phone: +31615636666

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.